P85β regulatory subunit of class I A PI3 kinase negatively regulates mast cell growth, maturation, and leukemogenesis

Subha Krishnan, Raghuveer Singh Mali, Baskar Ramdas, Emily Sims, Peilin Ma, Joydeep Ghosh, Veerendra Munugalavadla, Philip Hanneman, Joal D. Beane, Reuben Kapur

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We show that loss of p85α inhibits the growth and maturation of mast cells, whereas loss of p85β enhances this process. Whereas restoring the expression of p85α in P85α -/- cells restores these functions, overexpression of p85β has the opposite effect. Consistently, overexpression of p85β in WT mast cells represses KIT-induced proliferation and IL-3-mediated maturation by inhibiting the expression of Microphthalmia transcription factor. Because p85α and p85β differ in their N-terminal sequences, chimeric proteins consisting of amino or carboxy-terminal of p85α and/or p85β do not rescue the growth defects of p85α -/-cells, suggesting cooperation between these domains for normal mast cell function. Loss of p85β impaired ligand induced KIT receptor internalization and its overexpression enhanced this process, partly because of increased binding of c-Cbl to p85β relative to p85α. In vivo, loss of p85β resulted in increased mast cells, and bone marrow transplantation of cells overexpressing p85β resulted in significant reduction in some tissue mast cells. Overexpression of p85β suppressed the growth of oncogenic KIT-expressing cells in vitro and prolonged the survival of leukemic mice in vivo. Thus, p85α and p85β differentially regulate SCF and oncogenic KIT-induced signals in myeloid lineage-derived mast cells.

Original languageEnglish
Pages (from-to)3951-3961
Number of pages11
JournalBlood
Volume119
Issue number17
DOIs
StatePublished - Apr 19 2012

Fingerprint

Cell growth
Phosphatidylinositol 3-Kinases
Mast Cells
Growth
Microphthalmia-Associated Transcription Factor
Interleukin-3
Bone
Cells
Tissue
Ligands
Bone Marrow Transplantation
Defects
Proteins

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

P85β regulatory subunit of class I A PI3 kinase negatively regulates mast cell growth, maturation, and leukemogenesis. / Krishnan, Subha; Mali, Raghuveer Singh; Ramdas, Baskar; Sims, Emily; Ma, Peilin; Ghosh, Joydeep; Munugalavadla, Veerendra; Hanneman, Philip; Beane, Joal D.; Kapur, Reuben.

In: Blood, Vol. 119, No. 17, 19.04.2012, p. 3951-3961.

Research output: Contribution to journalArticle

Krishnan, S, Mali, RS, Ramdas, B, Sims, E, Ma, P, Ghosh, J, Munugalavadla, V, Hanneman, P, Beane, JD & Kapur, R 2012, 'P85β regulatory subunit of class I A PI3 kinase negatively regulates mast cell growth, maturation, and leukemogenesis', Blood, vol. 119, no. 17, pp. 3951-3961. https://doi.org/10.1182/blood-2011-05-355602
Krishnan, Subha ; Mali, Raghuveer Singh ; Ramdas, Baskar ; Sims, Emily ; Ma, Peilin ; Ghosh, Joydeep ; Munugalavadla, Veerendra ; Hanneman, Philip ; Beane, Joal D. ; Kapur, Reuben. / P85β regulatory subunit of class I A PI3 kinase negatively regulates mast cell growth, maturation, and leukemogenesis. In: Blood. 2012 ; Vol. 119, No. 17. pp. 3951-3961.
@article{46b6289f660a42199e2b08bf52379f51,
title = "P85β regulatory subunit of class I A PI3 kinase negatively regulates mast cell growth, maturation, and leukemogenesis",
abstract = "We show that loss of p85α inhibits the growth and maturation of mast cells, whereas loss of p85β enhances this process. Whereas restoring the expression of p85α in P85α -/- cells restores these functions, overexpression of p85β has the opposite effect. Consistently, overexpression of p85β in WT mast cells represses KIT-induced proliferation and IL-3-mediated maturation by inhibiting the expression of Microphthalmia transcription factor. Because p85α and p85β differ in their N-terminal sequences, chimeric proteins consisting of amino or carboxy-terminal of p85α and/or p85β do not rescue the growth defects of p85α -/-cells, suggesting cooperation between these domains for normal mast cell function. Loss of p85β impaired ligand induced KIT receptor internalization and its overexpression enhanced this process, partly because of increased binding of c-Cbl to p85β relative to p85α. In vivo, loss of p85β resulted in increased mast cells, and bone marrow transplantation of cells overexpressing p85β resulted in significant reduction in some tissue mast cells. Overexpression of p85β suppressed the growth of oncogenic KIT-expressing cells in vitro and prolonged the survival of leukemic mice in vivo. Thus, p85α and p85β differentially regulate SCF and oncogenic KIT-induced signals in myeloid lineage-derived mast cells.",
author = "Subha Krishnan and Mali, {Raghuveer Singh} and Baskar Ramdas and Emily Sims and Peilin Ma and Joydeep Ghosh and Veerendra Munugalavadla and Philip Hanneman and Beane, {Joal D.} and Reuben Kapur",
year = "2012",
month = "4",
day = "19",
doi = "10.1182/blood-2011-05-355602",
language = "English",
volume = "119",
pages = "3951--3961",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "17",

}

TY - JOUR

T1 - P85β regulatory subunit of class I A PI3 kinase negatively regulates mast cell growth, maturation, and leukemogenesis

AU - Krishnan, Subha

AU - Mali, Raghuveer Singh

AU - Ramdas, Baskar

AU - Sims, Emily

AU - Ma, Peilin

AU - Ghosh, Joydeep

AU - Munugalavadla, Veerendra

AU - Hanneman, Philip

AU - Beane, Joal D.

AU - Kapur, Reuben

PY - 2012/4/19

Y1 - 2012/4/19

N2 - We show that loss of p85α inhibits the growth and maturation of mast cells, whereas loss of p85β enhances this process. Whereas restoring the expression of p85α in P85α -/- cells restores these functions, overexpression of p85β has the opposite effect. Consistently, overexpression of p85β in WT mast cells represses KIT-induced proliferation and IL-3-mediated maturation by inhibiting the expression of Microphthalmia transcription factor. Because p85α and p85β differ in their N-terminal sequences, chimeric proteins consisting of amino or carboxy-terminal of p85α and/or p85β do not rescue the growth defects of p85α -/-cells, suggesting cooperation between these domains for normal mast cell function. Loss of p85β impaired ligand induced KIT receptor internalization and its overexpression enhanced this process, partly because of increased binding of c-Cbl to p85β relative to p85α. In vivo, loss of p85β resulted in increased mast cells, and bone marrow transplantation of cells overexpressing p85β resulted in significant reduction in some tissue mast cells. Overexpression of p85β suppressed the growth of oncogenic KIT-expressing cells in vitro and prolonged the survival of leukemic mice in vivo. Thus, p85α and p85β differentially regulate SCF and oncogenic KIT-induced signals in myeloid lineage-derived mast cells.

AB - We show that loss of p85α inhibits the growth and maturation of mast cells, whereas loss of p85β enhances this process. Whereas restoring the expression of p85α in P85α -/- cells restores these functions, overexpression of p85β has the opposite effect. Consistently, overexpression of p85β in WT mast cells represses KIT-induced proliferation and IL-3-mediated maturation by inhibiting the expression of Microphthalmia transcription factor. Because p85α and p85β differ in their N-terminal sequences, chimeric proteins consisting of amino or carboxy-terminal of p85α and/or p85β do not rescue the growth defects of p85α -/-cells, suggesting cooperation between these domains for normal mast cell function. Loss of p85β impaired ligand induced KIT receptor internalization and its overexpression enhanced this process, partly because of increased binding of c-Cbl to p85β relative to p85α. In vivo, loss of p85β resulted in increased mast cells, and bone marrow transplantation of cells overexpressing p85β resulted in significant reduction in some tissue mast cells. Overexpression of p85β suppressed the growth of oncogenic KIT-expressing cells in vitro and prolonged the survival of leukemic mice in vivo. Thus, p85α and p85β differentially regulate SCF and oncogenic KIT-induced signals in myeloid lineage-derived mast cells.

UR - http://www.scopus.com/inward/record.url?scp=84860328809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860328809&partnerID=8YFLogxK

U2 - 10.1182/blood-2011-05-355602

DO - 10.1182/blood-2011-05-355602

M3 - Article

C2 - 22378847

AN - SCOPUS:84860328809

VL - 119

SP - 3951

EP - 3961

JO - Blood

JF - Blood

SN - 0006-4971

IS - 17

ER -